- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03618576
Balance Rehabilitation After Hip Fracture Surgery (BRS)
August 1, 2018 updated by: Sang Yoon Lee, Seoul National University Hospital
Effectiveness of the Computerized Balance Rehabilitation After Hip Fracture Surgery
The overall functional gain by balance rehabilitation after hip fracture surgery has not yet been fully investigated.
Therefore, clinical studies should be conducted to evaluate the effectiveness of systematic and safe balance rehabilitation in patients after hip fracture.
Investigators aim to evaluate the effect of computer-based balance specific exercise on the performance and balance ability of the elderly women who underwent hip fracture surgery.
Investigators also investigate the intervention can reduce their fear of falling and coping ability.
This study was designed as a prospective, open-label, single-center trial at a tertiary hospital setting.
During the 2-week postoperative intervention period, patients will participate in the hospital's exercise program beginning 5-7 days after hip fracture surgery.
All participants will follow the computer-based balance specific exercise program.
Functional outcomes will be measure periodically for 6 months after surgery.
Study Overview
Status
Unknown
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Anticipated)
40
Phase
- Not Applicable
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
65 years to 100 years (OLDER_ADULT)
Accepts Healthy Volunteers
No
Genders Eligible for Study
Female
Description
Inclusion Criteria:
- Elderly female patients (≥ 65 years old) who have undergone surgery for femoral neck, intertrochanteric, or subtrochanteric fracture, regardless of surgery type (internal fixation, bipolar hemiarthroplasty, or total hip arthroplasty)
Exclusion Criteria:
- 1) hip surgery for infection, arthritis, implant loosening, or avascular necrosis;
- 2) femoral shaft fracture, acetabular fracture, isolated fracture of the greater or lesser tuberosity, or periprosthetic fracture;
- 3) pathologic fracture;
- 4) combined multiple fracture;
- 5) revision surgery;
- 6) severe cognitive dysfunction (obey command ≤ 1 step);
- 7) cannot stand by supporting a fixed walker at 5 days after operation;
- 8) patients who refuse to participate in a clinical trial
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: NA
- Interventional Model: SINGLE_GROUP
- Masking: NONE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Balance exercise group
During the 2-week postoperative intervention period, patients will participate in the hospital's exercise program beginning 5-7 days after HFS.
All participants will follow the computer-based balance specific exercise (BSE) program.
|
Balance specific exercise consists of total 10 days' physical therapy (PT) sessions (twice per day for 60 min) after surgery.
It will be conducted with a computed posturographic system for diagnostics of balance and movement skills (Balance Master® System NeuroCom®) designed to objectively quantify balance and postural function of different origin.
PT (weight-bearing, strengthening, gait training, aerobic, and functional exercises) was gradually increased based on the patient's functional level.
Intensive patient education by multidisciplinary rehabilitation members was also provided.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change of Berg balance scale
Time Frame: Change from Baseline Berg balance scale at 6 months
|
Berg balance scale (total score; 0 to 56)
|
Change from Baseline Berg balance scale at 6 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Functional Ambulatory Category
Time Frame: Before intervention, After 2 weeks' intervention, 3 and 6 months after surgery
|
Functional Ambulatory Category (categorical score; 0 to 5)
|
Before intervention, After 2 weeks' intervention, 3 and 6 months after surgery
|
|
Functional Independence Measure: locomotion
Time Frame: Before intervention, After 2 weeks' intervention, 3 and 6 months after surgery
|
Functional Independence Measure (subscale of locomotion: 1 to 7)
|
Before intervention, After 2 weeks' intervention, 3 and 6 months after surgery
|
|
Modified falls efficacy scale
Time Frame: Before intervention, After 2 weeks' intervention, 3 and 6 months after surgery
|
Modified falls efficacy scale (total score: 0 to 140)
|
Before intervention, After 2 weeks' intervention, 3 and 6 months after surgery
|
|
Presence of Fear of falling
Time Frame: Before intervention, After 2 weeks' intervention, 3 and 6 months after surgery
|
Fear of falling (yes or no; by simple question "Are you afraid of falling?")
|
Before intervention, After 2 weeks' intervention, 3 and 6 months after surgery
|
|
Modified Barthel index
Time Frame: Before intervention, After 2 weeks' intervention, 3 and 6 months after surgery
|
Modified Barthel index (tota; score: 0 to 100)
|
Before intervention, After 2 weeks' intervention, 3 and 6 months after surgery
|
|
Short physical performance scale
Time Frame: Before intervention, After 2 weeks' intervention, 3 and 6 months after surgery
|
Short physical performance scale (total score: 0 to 12)
|
Before intervention, After 2 weeks' intervention, 3 and 6 months after surgery
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Anticipated)
August 1, 2018
Primary Completion (Anticipated)
December 1, 2019
Study Completion (Anticipated)
December 1, 2019
Study Registration Dates
First Submitted
July 19, 2018
First Submitted That Met QC Criteria
August 1, 2018
First Posted (Actual)
August 7, 2018
Study Record Updates
Last Update Posted (Actual)
August 7, 2018
Last Update Submitted That Met QC Criteria
August 1, 2018
Last Verified
August 1, 2018
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 20-2018-46
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.